GAS5 and asthma: Furthermore, it was shown that, in the treatment of steroid-resistant asthma, lncRNA GAS5 acts as a glucocorticoid receptor, and pro-inflammatory mediators increase the amount of GAS5 both in airway smooth muscle cells and in the airway epithelium [130].